Results 261 to 270 of about 45,820 (279)

Assessment of New Inflammatory Indexes in Systemic Sclerosis with Interstitial Lung Disease. [PDF]

Eurasian J Med
Ecesoy V, Ecesoy H.
europepmc   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

Arthritis &Rheumatology, EarlyView.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih, Shiow‐Ing Wang, Qing‐Wen Wang, James Cheng Chung Wei   +3 more
wiley   +1 more source

Initial Circulating CD138 Predicts End-Stage Kidney Disease in Patients with Microscopic Polyangiitis. [PDF]

Yonsei Med J
Pyo JY, Park YB, Lee SW.
europepmc   +1 more source

Reactive Oxygen Species–Induced Modifications of Fibrin Clots as a Link Between Immune Responses and Atherothrombosis in Systemic Lupus Erythematosus

Arthritis &Rheumatology, EarlyView.
Objective Cardiovascular events are major determinants of morbidity and mortality in systemic lupus erythematosus (SLE), particularly in patients with renal involvement. Although oxidative stress has been implicated in driving vascular and renal damage in SLE, the specific mechanisms remain unclear.
Matteo Becatti, Giacomo Emmi, Alessandra Bettiol, Amanda Mannucci, Flavia Rita Argento, Eleonora Fini, Serena Borghi, Francesca Nencini, Maria Nicastro, Irene Mattioli, Elena Silvestri, Augusto Vaglio, Domenico Prisco, Claudia Fiorillo   +13 more
wiley   +1 more source

Global Disease Control in Inflammatory Arthritis Patients with Fibromyalgia Multi-Failure to Biologic Drugs: Short-Term Impact of Target Therapies on Both Disease Courses. [PDF]

J Clin Med
Rotondo C, Stefania S, Nardella L, Colia R, Maruotti N, Rella V, Busto G, Barile R, Cantatore FP, Corrado A.   +9 more
europepmc   +1 more source

Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?

Arthritis &Rheumatology, EarlyView.
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify noninvasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in ...
Valentina Querin, Leonardo Palazzo, Agnes B. Fogo, Mark Haas, David R. W. Jayne, Liz Lightstone, Brad H. Rovin, Surya V. Seshan, Augusto Vaglio, Ioannis Parodis, Ingeborg M. Bajema, for the Lupus Nephritis Classification Steering Committee   +11 more
wiley   +1 more source

Non-specific uptake of ⁶⁸Ga-FAPI PET/CT in the pancreas and its related factor: a retrospective, single-center study. [PDF]

BMC Cancer
Xiao L, Yang L, Li L, Zhang W.
europepmc   +1 more source

The effect of administering synthetic protein signal transducers and activators transcription 5a on total leukocytes, leukocyte differentials and erythrocyte indices on broilers is significant

Ratna Damayanti, Anwar Ma’ruf, M. Gandul Atik Yuliani, Kuncoro Puguh Santoso, Azzahra Nourish Salsabilla, Muhammad Zuhdianto Nugroho, Nusdianto Triakoso, Yeni Dhamayanti, Mufasirin Mufasirin, Supriyadi Supriyadi   +9 more
openalex   +1 more source

A case-control study on the diagnostic role of Omega-3 fatty acid levels in erythrocyte membranes of critically ill patients. [PDF]

Sci Rep
Dorchin M, Nasiri-Jounaghani M, Hashemi-Javaheri FS, Safarian M, Bagheri-Moghaddam A, Norouzy A, Khadem-Rezaiyan M, Hejazi S, Arabi M.   +8 more
europepmc   +1 more source

Development and validation of the manual disease activity score (MDAS) for rheumatoid arthritis. [PDF]

Rheumatol Immunol Res
Salim B, Nasim A, Jahan S, Perveen S, Samreen S, Gul H, Afzal A, Rizwan NUA, Ahmed M, Yasmin S.   +9 more
europepmc   +1 more source